Tango Therapeutics, Inc. (TNGX)
22.52
-0.24
(-1.05%)
USD |
NASDAQ |
Sep 04, 16:00
22.52
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics SG&A Expense (TTM) : 56.51M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.51M |
| March 31, 2026 | 45.26M |
| December 31, 2025 | 41.51M |
| September 30, 2025 | 42.84M |
| June 30, 2025 | 45.13M |
| March 31, 2025 | 44.56M |
| December 31, 2024 | 43.75M |
| September 30, 2024 | 41.76M |
| June 30, 2024 | 39.75M |
| March 31, 2024 | 38.15M |
| December 31, 2023 | 35.50M |
| September 30, 2023 | 34.28M |
| June 30, 2023 | 33.17M |
| Date | Value |
|---|---|
| March 31, 2023 | 31.23M |
| December 31, 2022 | 30.02M |
| September 30, 2022 | 28.20M |
| June 30, 2022 | 24.54M |
| March 31, 2022 | 20.94M |
| December 31, 2021 | 17.60M |
| September 30, 2021 | 14.55M |
| June 30, 2021 | 12.63M |
| March 31, 2021 | 9.002M |
| December 31, 2020 | 5.534M |
| September 30, 2020 | 2.518M |
| June 30, 2020 | 0.0005M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 330.91M |
| Erasca, Inc. | 41.80M |
| Beam Therapeutics, Inc. | 125.40M |
| NovelStem International Corp. | 0.1201M |
| Brainstorm Cell Therapeutics, Inc. | 6.474M |